151 related articles for article (PubMed ID: 28621442)
1. Dendritic-cell-based immunotherapy evokes potent anti-tumor immune responses in CD105+ human renal cancer stem cells.
Zhang XF; Weng DS; Pan K; Zhou ZQ; Pan QZ; Zhao JJ; Tang Y; Jiang SS; Chen CL; Li YQ; Zhang HX; Chang AE; Wicha MS; Zeng YX; Li Q; Xia JC
Mol Carcinog; 2017 Nov; 56(11):2499-2511. PubMed ID: 28621442
[TBL] [Abstract][Full Text] [Related]
2. Role of HLA-G and extracellular vesicles in renal cancer stem cell-induced inhibition of dendritic cell differentiation.
Grange C; Tapparo M; Tritta S; Deregibus MC; Battaglia A; Gontero P; Frea B; Camussi G
BMC Cancer; 2015 Dec; 15():1009. PubMed ID: 26704308
[TBL] [Abstract][Full Text] [Related]
3. Renal carcinoma CD105-/CD44- cells display stem-like properties in vitro and form aggressive tumors in vivo.
Fiedorowicz M; Khan MI; Strzemecki D; Orzeł J; Wełniak-Kamińska M; Sobiborowicz A; Wieteska M; Rogulski Z; Cheda L; Wargocka-Matuszewska W; Kilian K; Szczylik C; Czarnecka AM
Sci Rep; 2020 Mar; 10(1):5379. PubMed ID: 32214151
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell based immunotherapy using tumor stem cells mediates potent antitumor immune responses.
Dashti A; Ebrahimi M; Hadjati J; Memarnejadian A; Moazzeni SM
Cancer Lett; 2016 Apr; 374(1):175-185. PubMed ID: 26803056
[TBL] [Abstract][Full Text] [Related]
5. Generation of anti-tumour immune response using dendritic cells pulsed with carbonic anhydrase IX-Acinetobacter baumannii outer membrane protein A fusion proteins against renal cell carcinoma.
Kim BR; Yang EK; Kim DY; Kim SH; Moon DC; Lee JH; Kim HJ; Lee JC
Clin Exp Immunol; 2012 Jan; 167(1):73-83. PubMed ID: 22132887
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic efficacy of dendritic cells pulsed by autologous tumor cell lysate in combination with CIK cells on advanced renal cell carcinoma].
Wang H; Feng F; Zhu M; Wang R; Wang X; Wu Y; Zhuang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jan; 31(1):67-71. PubMed ID: 25575061
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of a dendritic cell vaccine for murine renal cell carcinoma by CpG oligonucleotides.
Chagnon F; Tanguay S; Ozdal OL; Guan M; Ozen ZZ; Ripeau JS; Chevrette M; Elhilali MM; Thompson-Snipes LA
Clin Cancer Res; 2005 Feb; 11(3):1302-11. PubMed ID: 15709202
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells loaded with exosomes derived from cancer stem cell-enriched spheroids as a potential immunotherapeutic option.
Naseri M; Zöller M; Hadjati J; Ghods R; Ranaei Pirmardan E; Kiani J; Eini L; Bozorgmehr M; Madjd Z
J Cell Mol Med; 2021 Apr; 25(7):3312-3326. PubMed ID: 33634564
[TBL] [Abstract][Full Text] [Related]
9. Immunostimulatory activity of dendritic cells pulsed with carbonic anhydrase IX and Acinetobacter baumannii outer membrane protein A for renal cell carcinoma.
Kim BR; Yang EK; Kim SH; Moon DC; Kim HJ; Lee JC; Kim DY
J Microbiol; 2011 Feb; 49(1):115-20. PubMed ID: 21369988
[TBL] [Abstract][Full Text] [Related]
10. Functional significance of CD105-positive cells in papillary renal cell carcinoma.
Matak D; Brodaczewska KK; Szczylik C; Koch I; Myszczyszyn A; Lipiec M; Lewicki S; Szymanski L; Zdanowski R; Czarnecka AM
BMC Cancer; 2017 Jan; 17(1):21. PubMed ID: 28056882
[TBL] [Abstract][Full Text] [Related]
11. Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells.
Khan MI; Czarnecka AM; Lewicki S; Helbrecht I; Brodaczewska K; Koch I; Zdanowski R; Król M; Szczylik C
PLoS One; 2016; 11(11):e0165718. PubMed ID: 27812180
[TBL] [Abstract][Full Text] [Related]
12. [Specific cellular immunotherapy of renal cell carcinoma. Current status and prospects].
Ringhoffer M; Gschwend JE
Urologe A; 2002 May; 41(3):249-57. PubMed ID: 12132274
[TBL] [Abstract][Full Text] [Related]
13. DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumors.
Lim DS; Kim JH; Lee DS; Yoon CH; Bae YS
Cancer Immunol Immunother; 2007 Nov; 56(11):1817-29. PubMed ID: 17443323
[TBL] [Abstract][Full Text] [Related]
14. Dysfunctional DC subsets in RCC patients: ex vivo correction to yield an effective anti-cancer vaccine.
Gigante M; Blasi A; Loverre A; Mancini V; Battaglia M; Selvaggi FP; Maiorano E; Napoli A; Castellano G; Storkus WJ; Gesualdo L; Ranieri E
Mol Immunol; 2009 Feb; 46(5):893-901. PubMed ID: 19041139
[TBL] [Abstract][Full Text] [Related]
15. Immune response induced in vitro by CD16- and CD16+ monocyte-derived dendritic cells in patients with metastatic renal cell carcinoma treated with dendritic cell vaccines.
Arroyo JC; Gabilondo F; Llorente L; Meraz-Ríos MA; Sánchez-Torres C
J Clin Immunol; 2004 Jan; 24(1):86-96. PubMed ID: 14997038
[TBL] [Abstract][Full Text] [Related]
16. Telomerase pulsed dendritic cells for immunotherapy for renal cell carcinoma.
Sievers E; Albers P; Schmidt-Wolf IG; Märten A
J Urol; 2004 Jan; 171(1):114-9. PubMed ID: 14665857
[TBL] [Abstract][Full Text] [Related]
17. Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma.
Figlin RA; Tannir NM; Uzzo RG; Tykodi SS; Chen DYT; Master V; Kapoor A; Vaena D; Lowrance W; Bratslavsky G; DeBenedette M; Gamble A; Plachco A; Norris MS; Horvatinovich J; Tcherepanova IY; Nicolette CA; Wood CG;
Clin Cancer Res; 2020 May; 26(10):2327-2336. PubMed ID: 32034074
[TBL] [Abstract][Full Text] [Related]
18. Human renal cell carcinoma induces a dendritic cell subset that uses T-cell crosstalk for tumor-permissive milieu alterations.
Figel AM; Brech D; Prinz PU; Lettenmeyer UK; Eckl J; Turqueti-Neves A; Mysliwietz J; Anz D; Rieth N; Muenchmeier N; Buchner A; Porubsky S; Siegert SI; Segerer S; Nelson PJ; Noessner E
Am J Pathol; 2011 Jul; 179(1):436-51. PubMed ID: 21703422
[TBL] [Abstract][Full Text] [Related]
19. Efficient responses in a murine renal tumor model by electroloading dendritic cells with whole-tumor lysate.
Weiss JM; Allen C; Shivakumar R; Feller S; Li LH; Liu LN
J Immunother; 2005; 28(6):542-50. PubMed ID: 16224271
[TBL] [Abstract][Full Text] [Related]
20. Antigen-specific T cell response from dendritic cell vaccination using side population cell-associated antigens targets hepatocellular carcinoma.
Li X; Zhang Z; Lin G; Gao Y; Yan Z; Yin H; Sun B; Wang F; Zhang H; Chen H; Cao D
Tumour Biol; 2016 Aug; 37(8):11267-78. PubMed ID: 26951511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
